FDA has had to bridge gaps in access to postmarketing surveillance data for COVID-19 vaccines. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
